NCT03494062

Brief Summary

Juvenile Takayasu disease is characterized by chronic inflammation that leads to vascular disease. Exercise may render anti-inflammatory effects and protect against cardiovascular events. This trial aims to investigate the therapeutic role of exercise in juvenile Takayasu disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

March 5, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 11, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2019

Completed
Last Updated

April 11, 2018

Status Verified

April 1, 2018

Enrollment Period

1.8 years

First QC Date

March 5, 2018

Last Update Submit

April 10, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Arterial inflammation

    as assessed by positron emission tomography - magnetic ressonance (PET-MR)

    12 weeks

  • Blood inflammatory markers

    interleukin-6, interleukin 10, interleukin-12

    12 weeks

  • Blood inflammatory marker

    C-reactive protein

    12 weeks

  • velocity sedimentation rate

    velocity sedimentation rate

    12 weeks

Secondary Outcomes (14)

  • Maximal aerobic capacity

    12 weeks

  • Body composition

    12 weeks

  • Timed stands test

    12 weeks

  • timed-up-and-go test

    12 weeks

  • Isometric strength

    12 weeks

  • +9 more secondary outcomes

Study Arms (2)

Exercise

EXPERIMENTAL

Home-based exercise intervention

Behavioral: Exercise

Control

NO INTERVENTION

Usual care

Interventions

ExerciseBEHAVIORAL

Home-based exercise training

Exercise

Eligibility Criteria

Age7 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • diagnosis of juvenile Takayasu disease

You may not qualify if:

  • cardiac and renal insufficiency
  • physical limitation hampering exercise training
  • non-controlled metabolic disorders
  • associated chronic diseases (last 6 months)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sao Paulo

São Paulo, Castanho, 05303-000, Brazil

RECRUITING

Related Publications (1)

  • Astley C, Clemente G, Terreri MT, Carneiro CG, Lima MS, Buchpiguel CA, Leao Filho H, de Sa Pinto AL, Silva CA, Campos LMA, Aikawa NE, Gil S, Pereira RMR, Roschel H, Gualano B. Home-Based Exercise Training in Childhood-Onset Takayasu Arteritis: A Multicenter, Randomized, Controlled Trial. Front Immunol. 2021 Jul 28;12:705250. doi: 10.3389/fimmu.2021.705250. eCollection 2021.

MeSH Terms

Conditions

Takayasu Arteritis

Interventions

Exercise

Condition Hierarchy (Ancestors)

Aortic Arch SyndromesAortic DiseasesVascular DiseasesCardiovascular DiseasesArteritisVasculitisSkin Diseases, VascularSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Bruno BG Gualano, Professor

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Camilla CA Astley, Masters

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 5, 2018

First Posted

April 11, 2018

Study Start

March 5, 2018

Primary Completion

December 30, 2019

Study Completion

December 30, 2019

Last Updated

April 11, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations